Procter & Gamble released its Q1 2025 earnings report, revealing a slight decline in sales due to a weakened Chinese economy and conflict in the Middle East. Despite these challenges, the results were largely in line with Wall Street's expectations, and the company maintained its full-year guidance. There was little reaction after the data, the stock price is up 0.4% to $172. Implied volatility after earnings based on historical data was 1.22% with average surprise of 3.56%.

Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appHighlights
- Net sales fell by 1% compared to the same period last year
- Earnings per share (EPS) of $1.93, beating estimates by $0.03
- Revenue of $21.9 billion, slightly below the expected $22.02 billion
- Profits of $4.0 billion, a 12% decline from the year-earlier period
- Maintained fiscal 2025 guidance for sales and earnings growth

Analyst estimates Source: Bloomberg
Key Metrics
- Net sales: -1% year-over-year
- Sales volume: Flat (declines in beauty and healthcare offset by growth in grooming, fabric, and home care)
- Organic sales of skin-care products: -20% (primarily due to SK-II brand in China)
- EPS: $1.93 (beat estimates of $1.90)
- Revenue: $21.9 billion (missed estimates of $22.02 billion)
Segment Performance
- Beauty and healthcare: Declined in sales volume
- Grooming, fabric, and home care: Showed growth in sales volume
- SK-II brand: Significant decline due to weaker economic conditions in China and anti-Japan sentiment
Outlook
- Maintained fiscal 2025 guidance:
- All-in sales growth: 2% to 4%
- Organic sales growth: 3% to 5%
- Diluted net earnings per share growth: 10% to 12%
- Core earnings per share growth: 5% to 7% (equating to $6.91 to $7.05 per share)
- Expected commodity cost headwind of approximately $200 million after tax ($0.08 per share)
- Foreign exchange impact expected to be neutral
- Core effective tax rate: 20% to 21%
- Capital spending: 4% to 5% of fiscal 2025 net sales
- Adjusted free cash flow productivity: 90%
- Planned dividend payments: around $10 billion
- Planned share repurchases: $6 to $7 billion
Additional Notes
- P&G has no plans to cut prices in the U.S. market
- The company sees consumers trading up to P&G brands despite economic pressures
- Global food makers like PepsiCo and Nestlé have warned of weaker consumer demand
- P&G's stock price closed at $172.28, up 2.57% in the last 3 months and 16.21% in the last 12 months
- The company received 3 positive and 13 negative EPS revisions in the last 90 days
There was little reaction after the data, the stock price is up 0.4% to $172. Implied volatility after earnings based on historical data was 1.22% with average surprise of 3.56%.

Implied volatility Source: Bloomberg
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.